Doctor Ahmed Farouk Mohamed Elamin
Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital
Event: EuroPrevent 2017
Topic: Lipids
Session: Diabetes/ Lipids/Obesity/Nutrition_Part 2
ESC 365 is supported by
